Skip to main content
Tech.euFundingExplorerBeta

Cutiss

CUTISS is a clinical TechBio company that develops and manufactures personalized skin tissue therapeutics for patients requiring skin surgery.

Cutiss has raised €82M across 4 funding rounds from 6 investors, most recently a Series C round in Sep 2025. Based in Zurich, Switzerland; active in Wellness & Beauty. Data as of 28 Oct 2026.

Total raised
€82M
€82,157,574
Funding rounds
4
Investors
6
distinct backers
Active since
2018-02
latest 2025-09

Funding by year

EUR raised per year
Cutiss — funding by year — interactive chart.
Data table
Cutiss — funding by year
2018€6.2M
2020€18M
2022€300k
2025€58M

Signals

High confidence
Raise-next likelihood79
base rate 50% for Series C
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood25
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 4 rounds raised
  • ▲ 8y since founding (typical exit age)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector or country

Global coverage: FundingData